Effect of high dose of steroid on plateletcount in acute stage of dengue Fever with thrombocytopenia
- PMID: 23998074
- PMCID: PMC3749644
- DOI: 10.7860/JCDR/2013/6135.3143
Effect of high dose of steroid on plateletcount in acute stage of dengue Fever with thrombocytopenia
Abstract
Background: Dengue infection is the most rapidly spreading mosquito-borne viral disease in the world and an estimated 50 million dengue infections reported annually. The pathogenesis of Thrombocytopenia in dengue fever (DF) is not clearly understood. Increased peripheral destruction of antibody coated platelets and acute bone marrow suppression were strongly suspected as the possible mechanism. This often leads to life threatening dengue hemorrhagic fever (DHF) and Dengue shock syndrome (DSS). Steroids are used in the treatment of Idiopathic thrombocytopenic purpura to increase the platelet count which is mediated by auto antibodies .This hypothesis would support the use of steroids in dengue fever.
Aim and objectives: The objective of this study was to test whether an intravenous high dose dexamethasone was efficacious in increasing the platelet count in acute stage of dengue fever with thrombocytopenia.
Methods: During the study period between June 2010 - 2011 in JSS Hospital Mysore, 127 patients were screened for dengue fever with thrombocytopenia (<50000/cumm) and 61patients were randomly allocated, 30 to the study group and 31 to the control group, in an open labeled study. The study group received intravenous dexamethasone 8mg initially followed by 4 mg every 8 h thereafter for 4 days and IV fluids whenever required. The control Group received only IV fluids and antipyretics whenever it was indicated. The daily measurement of platelet count was carried out in all patients from the day of enrolment to the fourth day of post treatment.
Results: The baseline data (age, sex, and the mean duration of the illness, Hb%, haematocrit, and platelets) were similar in both the groups. The analysis of variance (ANOVA) statistics showed a significant linear association of the mean platelet counts with the days in either group. The mean platelet counts increased steadily in both the groups from days 1 to 4: day1 (0.687), day2 (0.34), day3 (0.530) and day4 (0.844). There was no significant difference between the two groups.
Conclusion: We conclude that at a high dose dexamethasone regimen was not effective in achieving a higher rise in the platelet count in the acute stage of dengue fever.
Keywords: DHF; DSS; Dengue fever; Dexamethasone; Thrombocytopenia.
Figures
Similar articles
-
Efficacy of low dose dexamethasone in severe thrombocytopenia caused by dengue fever: a placebo controlled study.Postgrad Med J. 2009 Oct;85(1008):525-9. doi: 10.1136/pgmj.2008.078444. Postgrad Med J. 2009. PMID: 19789191 Clinical Trial.
-
Investigation of the efficacy and safety of eltrombopag to correct thrombocytopenia in moderate to severe dengue patients - a phase II randomized controlled clinical trial.EClinicalMedicine. 2020 Nov 21;29-30:100624. doi: 10.1016/j.eclinm.2020.100624. eCollection 2020 Dec. EClinicalMedicine. 2020. PMID: 33294822 Free PMC article.
-
Oxidative stress in severe dengue viral infection: association of thrombocytopenia with lipid peroxidation.Platelets. 2008 Sep;19(6):447-54. doi: 10.1080/09537100802155284. Platelets. 2008. PMID: 18925513
-
Alternate hypothesis on the pathogenesis of dengue hemorrhagic fever (DHF)/dengue shock syndrome (DSS) in dengue virus infection.Exp Biol Med (Maywood). 2008 Apr;233(4):401-8. doi: 10.3181/0707-MR-198. Exp Biol Med (Maywood). 2008. PMID: 18367628 Review.
-
Dengue hemorrhagic fever: clinical manifestations and management.Indian J Pediatr. 1999 Jan-Feb;66(1):93-101. doi: 10.1007/BF02752362. Indian J Pediatr. 1999. PMID: 10798041 Review.
Cited by
-
Effectiveness of corticosteroid in the treatment of dengue - A systemic review.Heliyon. 2018 Sep 22;4(9):e00816. doi: 10.1016/j.heliyon.2018.e00816. eCollection 2018 Sep. Heliyon. 2018. PMID: 30258999 Free PMC article. Review.
-
Thrombopoietin Receptor Agonists: Can These Be the Future Answer to the Deadly Thrombocytopenia in Dengue Fever?Cureus. 2019 Apr 1;11(4):e4361. doi: 10.7759/cureus.4361. Cureus. 2019. PMID: 31192066 Free PMC article. Review.
-
Case of Near Fatal Massive Intracerebral Bleed Secondary to Cerebral Venous Thrombosis in a Patient with Dengue and Refractory Thrombocytopenia.Indian J Crit Care Med. 2020 Feb;24(2):138-140. doi: 10.5005/jp-journals-10071-23351. Indian J Crit Care Med. 2020. PMID: 32205948 Free PMC article.
-
Authors reply.Rev Inst Med Trop Sao Paulo. 2014 Sep-Oct;56(5):459-60. doi: 10.1590/s0036-46652014000500018. Rev Inst Med Trop Sao Paulo. 2014. PMID: 25229232 Free PMC article. No abstract available.
-
Atrial Fibrillation Due to Acute Myocarditis During Dengue Haemorrhagic Fever.J Clin Diagn Res. 2015 Sep;9(9):OL01-2. doi: 10.7860/JCDR/2015/13375.6514. Epub 2015 Sep 1. J Clin Diagn Res. 2015. PMID: 26500943 Free PMC article. No abstract available.
References
-
- WHO. Dengue Guideline for diagnosis, treatment, prevention and control. Geneva: World Health Organization. 2009. - PubMed
-
- Guzman MG, Kauri G. Dengue: an update. The Lancet Infectious Diseases. 2002;2:33–42. - PubMed
-
- Stasi R, Provan D. Management of immune thrombocytopenic purpura in adults. Mayo Clin Proc. 2004;79:504–22. - PubMed
-
- Messer WB, Vitarana UT, Sivananthan K, et al. Epidemiology of dengue in Sri Lanka before and after the emergence of epidemic dengue hemorrhagic fever. Am J Trop Med Hyg. 2002;66:765–73. - PubMed
-
- Kularatne SAM. Survey on the management of dengue infection in Sri Lanka: Opinion of physicians and pediatricians. Southeast Asian J Trop Med Pub Health. 2005;36:1198–200. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous